---
figid: PMC9513432__fphar-13-1002915-g004
figtitle: How sphingolipids affect T cells in the resolution of inflammation
organisms:
- Candida dubliniensis
- Malus domestica
- Homo sapiens
- Mus musculus
- Severe acute respiratory syndrome coronavirus 2
- unidentified
- Corynebacterium phage gamma
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Arabidopsis thaliana
pmcid: PMC9513432
filename: fphar-13-1002915-g004.jpg
figlink: /pmc/articles/PMC9513432/figure/F4/
number: F4
caption: Sphingolipid influence on Th17 and Treg imbalance. In a pro-inflammatory
  setting Th17 differentiation is mediated through mTOR which is activated by S1P1
  and IL6 Receptor signalling. MTOR activates S6 phosphorylation resulting in a Th17
  favouring expression pattern with ROR(γ)t and IL-17 expression. Blockade of Smad3
  activity mediated via S1P1 dependent mTOR pathway inhibits Foxp3 expression. When
  S1P1 is antagonized, mTOR signalling is diminished and activity of Smad3 mediated
  through the TGFβ pathway is sustained. Smad3 enhances Foxp3 expression, which impairs
  SMS1 transcription resulting in an increased level of ceramides in the cytosol.
  PP2A interacts with those ceramides and attenuates mTOR signalling.
papertitle: How sphingolipids affect T cells in the resolution of inflammation.
reftext: Jennifer Christina Hartel, et al. Front Pharmacol. 2022;13:1002915.
year: '2022'
doi: 10.3389/fphar.2022.1002915
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: ceramides | gangliosides | S1P | lipid rafts | treg | Th17 | bioactive lipids
automl_pathway: 0.94818
figid_alias: PMC9513432__F4
figtype: Figure
redirect_from: /figures/PMC9513432__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9513432__fphar-13-1002915-g004.html
  '@type': Dataset
  description: Sphingolipid influence on Th17 and Treg imbalance. In a pro-inflammatory
    setting Th17 differentiation is mediated through mTOR which is activated by S1P1
    and IL6 Receptor signalling. MTOR activates S6 phosphorylation resulting in a
    Th17 favouring expression pattern with ROR(γ)t and IL-17 expression. Blockade
    of Smad3 activity mediated via S1P1 dependent mTOR pathway inhibits Foxp3 expression.
    When S1P1 is antagonized, mTOR signalling is diminished and activity of Smad3
    mediated through the TGFβ pathway is sustained. Smad3 enhances Foxp3 expression,
    which impairs SMS1 transcription resulting in an increased level of ceramides
    in the cytosol. PP2A interacts with those ceramides and attenuates mTOR signalling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD3
  - IL17A
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - MTOR
  - IL6
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RBM14
  - KANK2
  - CACYBP
  - TP53INP1
  - TSACC
  - RBM14-RBM4
  - TRE-TTC3-1
  - TREH
  - IL10
  - FOXP3
  - SGMS1
  - PTPA
  - MBTPS1
  - GEMIN2
  - SCAF11
  - NHERF2
  - ZEB2
  - Smad3
  - Il17a
  - Mtor
  - Il6
  - Akt1
  - Pik3r1
  - Cacybp
  - Trp53inp1
  - Tsacc
  - Sipd1
  - Il10
  - Foxp3
  - Sgms1
  - Ppp2ca
  - Ppp2r1a
  - S1pr1
  - Mbtps1
  - Zeb2
  - Nherf2
  - Gemin2
  - Scaf11
  - Tor
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Tps1
  - ks-1
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - cer
  - S1P
  - sip1
  - CG10939
  - HSPC300
  - VPS34
  - PP2A
  - SIP1
---
